Regen Biopharma, Inc. (RGBP)
0.0012
0.00 (0.00%)
USD |
OTCM |
Feb 20, 11:05
Regen Biopharma Total Liabilities (Quarterly) : 6.810M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 514.76M |
| Curis, Inc. | 42.33M |
| LadRx Corp. | 2.395M |
| Plus Therapeutics, Inc. | 13.62M |
| Windtree Therapeutics, Inc. | 27.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.2371M |
| Shareholders Equity (Quarterly) | -6.573M |
| Debt to Equity Ratio | -0.1642 |
| Current Ratio | 0.0348 |
| Net Debt Paydown Yield | -7.15% |